Aimei Health Technology (NASDAQ:AFJK - Get Free Report)'s stock had its "sell (d+)" rating reaffirmed by investment analysts at Weiss Ratings in a research report issued on Friday,Weiss Ratings reports.
Aimei Health Technology Stock Performance
Shares of AFJK stock traded down $0.07 on Friday, reaching $11.33. The stock had a trading volume of 1,007 shares, compared to its average volume of 3,936. Aimei Health Technology has a 1 year low of $10.24 and a 1 year high of $11.49. The company has a 50 day simple moving average of $11.31 and a 200 day simple moving average of $11.18. The stock has a market cap of $69.36 million, a P/E ratio of 49.26 and a beta of -0.03.
Aimei Health Technology (NASDAQ:AFJK - Get Free Report) last posted its quarterly earnings results on Wednesday, August 13th. The company reported $0.07 EPS for the quarter.
Institutional Investors Weigh In On Aimei Health Technology
A number of large investors have recently made changes to their positions in AFJK. Polar Asset Management Partners Inc. purchased a new stake in Aimei Health Technology in the first quarter valued at $110,000. Quarry LP raised its holdings in Aimei Health Technology by 4.7% in the 1st quarter. Quarry LP now owns 157,081 shares of the company's stock valued at $1,729,000 after acquiring an additional 7,081 shares during the last quarter. Berkley W R Corp increased its holdings in shares of Aimei Health Technology by 23.6% during the 2nd quarter. Berkley W R Corp now owns 425,361 shares of the company's stock worth $4,704,000 after buying an additional 81,235 shares during the last quarter. Clear Street LLC increased its holdings in shares of Aimei Health Technology by 63.8% during the 2nd quarter. Clear Street LLC now owns 39,525 shares of the company's stock worth $441,000 after buying an additional 15,399 shares during the last quarter. Finally, Wellspring Financial Advisors LLC purchased a new position in shares of Aimei Health Technology during the 2nd quarter worth approximately $133,000. 45.58% of the stock is owned by hedge funds and other institutional investors.
About Aimei Health Technology
(
Get Free Report)
Aimei Health Technology Co, Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. It intends to acquires businesses in the biopharmaceutical, medical technology/device industries or diagnostic, and other services sectors.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Aimei Health Technology, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aimei Health Technology wasn't on the list.
While Aimei Health Technology currently has a Sell rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
